Cabaletta Bio Inc (CABA)
10.99
-0.22
(-1.96%)
USD |
NASDAQ |
May 24, 15:38
Cabaletta Bio Total Liabilities (Quarterly): 18.74M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 18.74M |
| December 31, 2023 | 17.45M |
| September 30, 2023 | 12.36M |
| June 30, 2023 | 10.50M |
| March 31, 2023 | 11.80M |
| December 31, 2022 | 12.45M |
| September 30, 2022 | 5.801M |
| June 30, 2022 | 6.486M |
| March 31, 2022 | 6.935M |
| December 31, 2021 | 8.38M |
| September 30, 2021 | 6.023M |
| Date | Value |
|---|---|
| June 30, 2021 | 5.601M |
| March 31, 2021 | 3.969M |
| December 31, 2020 | 5.18M |
| September 30, 2020 | 4.265M |
| June 30, 2020 | 3.263M |
| March 31, 2020 | 3.256M |
| December 31, 2019 | 3.147M |
| September 30, 2019 | 101.02M |
| June 30, 2019 | 1.876M |
| December 31, 2018 | 44.86M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.876M
Minimum
Jun 2019
101.02M
Maximum
Sep 2019
12.42M
Average
6.254M
Median
Total Liabilities (Quarterly) Benchmarks
| Editas Medicine Inc | 145.95M |
| ACADIA Pharmaceuticals Inc | 391.06M |
| Alnylam Pharmaceuticals Inc | 4.044B |
| Regeneron Pharmaceuticals Inc | 7.378B |
| Vertex Pharmaceuticals Inc | 5.371B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 240.46M |
| Shareholders Equity (Quarterly) | 221.72M |